Use of Acid Reflux Drugs Linked to Higher Risk of Migraine

People who take acid-reducing drugs may have a higher risk of migraine and other severe headache than people who do not take these medications, according to a study published in the April 24, 2024, online issue of Neurology® Clinical Practice, an official journal of the American Academy of Neurology. The acid-reducing drugs include proton pump inhibitors such as omeprazole and esomeprazole, histamine H2-receptor antagonists, or H2 blockers, such as cimetidine and famotidine, and antacid supplements.

Simulation reveals new mechanism for membrane fusion

An intricate simulation performed by UT Southwestern Medical Center researchers using one of the world’s most powerful supercomputers sheds new light on how proteins called SNAREs cause biological membranes to fuse.

Key to Unlocking the Secret of Degenerative Brain Disorders Found

A research team led by Dr. Kim Yun Kyung from the Brain Science Institute at the Korea Institute of Science and Technology (KIST), in collaboration with Professor Chang Young-Tae’s team from Pohang University of Science and Technology, has announced the development of a next-generation neuron labeling technology called NeuM.

Earlier Menopause Plus High Cardiovascular Risk May Lead to Cognitive Problems Later

Earlier menopause combined with higher risk of cardiovascular disease is linked to an increased risk of thinking and memory problems later, according to a new study published in the April 3, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. In this study, earlier menopause is defined as occurring before age 49.

UCLA Health neurologist receives award for innovative multiple sclerosis research

Dr. Rhonda Voskuhl, a professor of neurology at UCLA Health, has been awarded the 2024 John Dystel Prize for Multiple Sclerosis Research in recognition of her outstanding contributions to multiple sclerosis research and treatment.

Après une chirurgie de l’épilepsie : gérer les attentes et les soins

Avant la chirurgie, les personnes atteintes d’épilepsie subissent une longue évaluation et des tests approfondis. Mais après une opération chirurgicale, certains professionnels et défenseurs affirment que les gens sont injustement laissés seuls pour gérer le traitement et les soins, sans beaucoup d’aide ou de conseils.

Gene therapy offers hope for giant axonal neuropathy patients

A gene therapy developed by researchers at UT Southwestern Medical Center for a rare disease called giant axonal neuropathy (GAN) was well tolerated in pediatric patients and showed clear benefits, a new study reports. Findings from the phase one clinical trial, published in the New England Journal of Medicine, could offer hope for patients with this rare condition and a host of other neurological diseases.

Nerve decompression shows promise for diabetic neuropathy patients

Surgical nerve decompression, used to treat conditions such as carpal tunnel syndrome and sciatica, could play a role in relieving the pain of diabetic neuropathy patients, researchers at UT Southwestern Medical Center found.

Do Veterans Who Experience Concussions Have an Increased Risk of Alzheimer’s?

Middle-age veterans who experienced concussions due to blasts from explosive devices may have biomarkers in their spinal fluid similar to people who develop Alzheimer’s disease, according to a new study published in the March 13, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Black People Half as Likely to Be Evaluated for Genetic Testing as White People

Genetic testing has become a more common way to diagnose and manage many neurologic conditions including dementia, Parkinson’s disease and epilepsy, but a new study has found not everyone may have the same level of access to these tests. Black people were half as likely as white people to be evaluated for genetic testing, according to a study published in the March 6, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Pediatric Neurologist Honored With Prestigious Research Award

Children’s Hospital Los Angeles (CHLA) neurologist Shafali Spurling Jeste, MD, has been named the 2024 recipient of the prestigious Martha Bridge Denckla Award from the Child Neurology Society. This award—named after a physician who pioneered the field of developmental cognitive neurology—honors physician-scientists of international standing who conduct research and clinical care focused on neurodevelopmental and neurobehavioral disorders.

“Talking about things that no one else will talk about”: Torie Robinson, host of Epilepsy Sparks Insights

Diagnosed with epilepsy at age 10, Torie Robinson uses her podcast to share knowledge with people with epilepsy, their families, and the public. Her episode topics range from the biochemistry of epilepsy to gastrointestinal issues and much, much more.

Gold nanoparticles reverse brain deficits in multiple sclerosis, Parkinson’s

Results from phase two clinical trials at UT Southwestern Medical Center showed that a suspension of gold nanocrystals taken daily by patients with multiple sclerosis (MS) and Parkinson’s disease (PD) significantly reversed deficits of metabolites linked to energy activity in the brain and resulted in functional improvements.

Hackensack Meridian Neuroscience Institute At Jersey Shore University Medical Center Now Providing Extraordinary Treatment to Improve Stroke Survivors’ Mobility

Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center completed its first Paired VNS™ Therapy case with a stroke survivor who has yet to regain her desired hand and arm function after five years of traditional physical and occupational therapy.

Device keeps brain alive, functioning separate from body

Researchers led by a team at UT Southwestern Medical Center have developed a device that can isolate blood flow to the brain, keeping the organ alive and functioning independent from the rest of the body for several hours.

Case Western Reserve University School of Medicine launches Institute for Glial Sciences

Case Western Reserve University has established an Institute for Glial Sciences to advance research of glial cells and their critical role in the health and diseases of the nervous systems, including multiple sclerosis, Alzheimer’s, pediatric leukodystrophies, Autism spectrum disorders, Parkinson’s disease and cancer.

Traditional Chinese medicine reduces risk after heart attack

A traditional Chinese medicine whose name means “to open the network of the heart” reduced the risk of heart attacks, deaths, and other major cardiovascular complications for at least a year after a first heart attack, a study led by UT Southwestern Medical Center researchers shows. The findings, published in JAMA, reveal the promise of this compound, one of the first traditional Chinese medicines tested in a large-scale, Western-style clinical trial.

Childhood Trauma Linked to Headaches in Adulthood

People who have experienced traumatic events in childhood such as abuse, neglect or household dysfunction may be more likely to experience headache disorders as adults, according to a meta-analysis published in the October 25, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology. This research does not prove that such experiences cause headaches; it only shows an association.

CRF Announces the 2023 Pulse-Setter Award Winners

The Cardiovascular Research Foundation (CRF) is proud to announce the winners of the 2023 Pulse-Setter Awards. The awardees will be honored at The Annual Pulse of the City Gala, CRF’s signature fundraising event, on December 8, 2023, at The Plaza in New York City. The Pulse-Setter Awards shine a spotlight on extraordinary individuals and initiatives whose dedication to innovation is driving positive change in medicine and health care.

FAU Receives $750,000 Philanthropic Grant for Alzheimer’s Disease

A $750,000 philanthropic grant from the Carl Angus DeSantis Foundation will help FAU develop partnerships and programs that will establish best practice for coordinated care and research for Alzheimer’s disease and related dementias.

Even Mild Head Injury Increases the Risk of Ischemic Stroke, Study Shows

Suffering a traumatic brain injury (TBI) – no matter how severe – is associated with a significantly increased risk of ischemic stroke in a diverse group of U.S. adults, according to new research being presented at the 148th Annual Meeting of the American Neurological Association (ANA). Suffering more than one head injury further increased the risk.

Sleep Plays a Major Role in Neurological Disorders Getting Good Sleep May Help Reduce Risk

Neurological disorders – including autism spectrum disorder (ASD), Alzheimer’s disease and Parkinson’s disease – cause sleep disturbances that make life extra challenging for people with those conditions. Improving sleep not only helps improve their quality of life, evidence is mounting that good sleep is vital for a healthy brain and may reduce the risk of some neurological disorders, according to neurologists speaking at the Presidential Symposium – Exploring Sleep Disturbances in CNS Disorders plenary session at the 148th Annual Meeting of the American Neurological Association (ANA).

Amanda C. Peltier, MD, MS, Receives AANEM’s 2023 Jun Kimura Outstanding Educator Award

The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) proudly announces Dr. Amanda C. Peltier as the 2023 Jun Kimura Outstanding Educator Award recipient for her numerous contributions and dedication to advancing medical education in the fields of neuromuscular (NM) and electrodiagnostic (EDX) medicine.

Bassam A. Bassam, MD, Receives AANEM’s 2023 Distinguished Physician Award

Rochester, Minn. (Sept. 09, 2023)- The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) proudly announces Dr. Bassam A. Bassam as the 2023 Distinguished Physician Award recipient for his exceptional contributions to patient care, research, and education in the fields of neuromuscular (NM) and electrodiagnostic (EDX) medicine.

Wexner Medical Center among first in nation to administer new gene therapy for ALS

The Ohio State University Wexner Medical Center is one of the first nationwide to administer a targeted gene therapy for patients with a specific form of amyotrophic lateral sclerosis (ALS), a neurodegenerative disease that affects the cells in the brain and spine.

Catching Up With Nursing Heroes as COVID-19 Pandemic Wanes

Throughout the COVID-19 pandemic, more than 3,200 Cedars-Sinai Medical Center nurses put on their protective gear and kept on going—providing the highest-quality patient care, conducting innovative research and creating new ways for patients to conveniently access Cedars-Sinai experts.